The future of medtech lies in diagnostics
The medical diagnostics sector is propelled forward by innovations in imaging, precision medicine, and rapid testing, with AI integration and improved accessibility fueling robust growth. Over the past five years, more than $24 billion of VC funding has been raised by diagnostics startups.
Our latest analyst note highlights the upward trajectory of the space, emphasized by an upcoming period of growth for mid- to late-stage diagnostic companies over the next few years. Investor interest in the next generation of diagnostic technology such as gene sequencing and point-of-care blood collection will propel the sector even further forward.
Table of contents
| Key takeaways | 1 |
| Introduction | 2 |
| Innovation landscape | 2 |
| Segment overviews | 4 |
| VC activity | 5 |
| Payment considerations | 8 |
| Startup spotlights | 8 |
| Outlook | 11 |
| Appendix | 12 |